Angiotensin AT
Angiotensin AT(2) receptor
Aortic aneurysm
Fibrosis
Heart failure
Inflammation
Myocardial infarction
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
16 Feb 2024
16 Feb 2024
Historique:
received:
05
10
2023
revised:
04
01
2024
accepted:
15
02
2024
medline:
19
2
2024
pubmed:
19
2
2024
entrez:
18
2
2024
Statut:
aheadofprint
Résumé
The angiotensin AT2 receptor (AT
Identifiants
pubmed: 38369211
pii: S0006-2952(24)00045-5
doi: 10.1016/j.bcp.2024.116062
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
116062Informations de copyright
Copyright © 2024. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Thomas Unger has received grants and honoraria for presentations from Boehringer Ingelheim and other pharmaceutical companies.